title: Association Between Gadolinium Contrast Exposure and the Risk of Parkinsonism.
authors.affiliation: Department of Surgery, Western University, London, Canada.
authors.forename: Blayne
authors.initials: B
authors.lastname: Welk
authors.affiliation: Institute for Clinical Evaluative Sciences, Ontario, Canada.
authors.forename: Eric
authors.initials: E
authors.lastname: McArthur
authors.affiliation: Department of Clinical Neurological Sciences, Western University, London, Canada.
authors.forename: Sarah A
authors.initials: SA
authors.lastname: Morrow
authors.affiliation: Department of Clinical Neurological Sciences, Western University, London, Canada.
authors.forename: Penny
authors.initials: P
authors.lastname: MacDonald
authors.affiliation: Institute for Clinical Evaluative Sciences, Ontario, Canada.
authors.forename: Jade
authors.initials: J
authors.lastname: Hayward
authors.affiliation: Department of Medical Imaging, Western University, London, Canada.
authors.forename: Andrew
authors.initials: A
authors.lastname: Leung
authors.affiliation: Department of Medical Imaging, Western University, London, Canada.
authors.forename: Andrea
authors.initials: A
authors.lastname: Lum
mesh_terms: D000368:Aged; D003287:Contrast Media / Q000009:adverse effects*; D005260:Female; D005682:Gadolinium / Q000009:adverse effects*; D005917:Globus Pallidus / Q000187:drug effects*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000706:statistics & numerical data; D008297:Male; D020734:Parkinsonian Disorders / Q000139:chemically induced*; D012306:Risk
chemical_list: D003287:Contrast Media; D005682:Gadolinium